These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1425833)

  • 1. Prognostic role of flow cytometry in superficial bladder cancer.
    Di Silverio F; von Heland M; De Berardinis E; Izzi R; Buscarini M; De Vita R; Forte R; Seccareccia F; Menotti A
    Eur Urol; 1992; 21 Suppl 1():22-5. PubMed ID: 1425833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis.
    Corrado F; Ferri C; Mannini D; Corrado G; Bertoni F; Bacchini P; Lelli G; Lieber MM; Song JM
    J Urol; 1991 Jun; 145(6):1159-63. PubMed ID: 2033684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study.
    Tachibana M; Miyakawa A; Miyakawa M; Saito S; Nakamura K; Baba S; Murai M
    Cancer Detect Prev; 1999; 23(2):155-62. PubMed ID: 10101597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
    Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
    J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
    Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
    J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.
    Shariat SF; Weizer AZ; Green A; Laucirica R; Frolov A; Wheeler TM; Lerner SP
    Urology; 2000 Nov; 56(5):735-40. PubMed ID: 11068290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry.
    Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP
    Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
    Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
    J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications.
    Cianciulli AM; Bovani R; Leonardo C; Iori F; Coletta AM; Marzano R; Antenucci A; Gandolfo GM; Laurenti C
    Eur J Histochem; 2001; 45(1):65-71. PubMed ID: 11411867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN; Daly JM
    Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
    Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
    Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.